Lateral Flow Contract Development

About ProGnosis Biotech

ProGnosis Biotech is an EU-based diagnostics company founded in 2015, developing and manufacturing ELISA and Lateral Flow Tests for food safety, clinical diagnostics, and hygiene monitoring. The company leverages its antigen-antibody technology platform to deliver rapid, reliable, and eco-friendly testing solutions validated by international bodies. With ISO-certified production and a growing portfolio, ProGnosis serves global markets while expanding into new areas like cardiac markers and contract manufacturing services.

Therapeutic Areas